Idorsia (XSWX:IDIA) Dividends per Share : CHF0.00 (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Dividends per Share?

Idorsia's dividends per share for the three months ended in Mar. 2024 was CHF0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was CHF0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Idorsia's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Idorsia Dividends per Share Historical Data

The historical data trend for Idorsia's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Dividends per Share Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Idorsia Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Idorsia's Dividends per Share

For the Biotechnology subindustry, Idorsia's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Idorsia's Dividend Yield % falls into.

Idorsia Dividends per Share Calculation

Dividends paid to per common share.

Idorsia (XSWX:IDIA) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Idorsia's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	Earnings per Share (Diluted) (Q: Mar. 2024 )
	=	0	/	0.13
	=	0.00

During the past 8 years, the highest Dividend Payout Ratio of Idorsia was 394.70. The lowest was 394.70. And the median was 394.70.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 8 years, the highest Dividend Yield of Idorsia was 56.71%. The lowest was 40.29%. And the median was 48.60%.

Idorsia Dividends per Share Related Terms

Thank you for viewing the detailed overview of Idorsia's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (XSWX:IDIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (XSWX:IDIA) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

IDRSF:USA IDIAz:UK 0RQE:UK

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (XSWX:IDIA) Headlines

No Headlines